Back

Twelve-months vessel healing profile following the novel resorbable magnesium scaffold implantation: an intravascular OCT analysis of the BIOMAG-I trial

27 August 2023 (12:15 - 12:50)
Organised by: Logo
Congress Presentation Part of: Drug-eluting stents Devices ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Masaru Seguchi

German Heart Center of Munich, Munich (Germany)

5 More presentations in this session

Presentation thumbnail
Treatment of coronary artery disease with sirolimus- versus paclitaxel-coated balloons
Doctor M. Madanchi (Hamilton, CA)
Abstract Slides Video
Presentation thumbnail
Association between high platelet reactivity and early stent thrombosis in patients with drug-eluting stent implantation
Doctor S. Lim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Vascular healing of Combo plus stents in patients with acute coronary syndrome
Doctor K. Shishido (Kamakura, JP)
Abstract Slides Video
Presentation thumbnail
Patient-level outcomes of patients undergoing resorbable magnesium scaffold (RMS) implantation stratified according to different subgroups: a post-hoc analysis of SHERPA MAGIC study
Doctor G. Pompei (Ravenna, IT)
Abstract Slides Video
Presentation thumbnail
Outcomes of drug eluting stents vs. drug eluting balloons. A single center experience.
Doctor M. Kheifets (Petah Tikva, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Drug-eluting stents

The Event

Event poster

ESC Congress 2023

27 August 2023 12:15 CET
You may be interested in
thumbnail
Congress Presentation
First in human study BIOMAG-I: 12 months results of the sirolimus eluting resorbable coronary magnesium scaffold system (DREAMS 3G) in the treatment of subjects with de novo coronary artery lesions
thumbnail
Congress Presentation
ABSORB bioresorbable scaffold (BRS) site late thrombosis treated with novel MagmarisRMS
thumbnail
Congress Presentation
Functional hemodynamic and wall shear stress assessment of a novel endoluminal fibrillated polymeric scaffold up to full resorption within 12 months in a preclinical in-vivo setting

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources